Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Research Square|February 26, 2024
Allostatic Load as a Predictor of Postoperative Complications in Patients with Breast CancerSamilia Obeng-Gyasi, J C Chen, Mohamed Elsaid, et al.
The Journal of Clinical Psychiatry|May 10, 2002
Prevalence of sexual dysfunction among newer antidepressantsAnita H Clayton, James F Pradko, Harry A Croft, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
Obesity Research|October 12, 2002
Bupropion SR vs. placebo for weight loss in obese patients with depressive symptomsAdesh K Jain, Roy A Kaplan, Kishore M Gadde, et al.
Psycho-Oncology|April 9, 2025
Combined Treatment With Cognitive Behavioral Therapy for Insomnia and Acceptance and Commitment Therapy Enhances Objective and Subjective Reports of Sleep in Patients With Advanced CancerSharla Wells-Di Gregorio, Stacy Flowers, Juan Peng, et al.
Pharmacoepidemiology and Drug Safety|October 7, 2010
Epidemiologic study of aripiprazole use and the incidence of suicide eventsMarianne Ulcickas Yood, Gerald Delorenze, Charles P Quesenberry, et al.
Oncoimmunology|October 21, 2016
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activatorPrashant Trikha, Robert L Plews, Andrew Stiff, et al.
International Journal of Radiation Oncology, Biology, Physics|December 8, 2025
Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 StudySasha Beyer, Jeffrey Hawley, Yevgeniya Gokun, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2024
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid CancerBhavana Konda, Eric J Sherman, Erminia Massarelli, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
Pageof 6